|
Volumn 162, Issue 15, 2002, Pages 1769-1774
|
Should we screen for hemochromatosis? An examination of evidence of downstream effects on morbidity and mortality
|
Author keywords
[No Author keywords available]
|
Indexed keywords
FERRITIN;
IRON;
TRANSFERRIN;
ADULT;
AGED;
AMBULATORY CARE;
ARTICLE;
DISEASE CLASSIFICATION;
FEMALE;
HEMOCHROMATOSIS;
HOSPITALIZATION;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MORBIDITY;
MORTALITY;
PRIORITY JOURNAL;
SCREENING;
TRANSFERRIN BLOOD LEVEL;
UNITED STATES;
ADOLESCENT;
ADULT;
AGED;
BIOLOGICAL MARKERS;
EVIDENCE-BASED MEDICINE;
FEMALE;
HEMOCHROMATOSIS;
HUMANS;
MALE;
MASS SCREENING;
MIDDLE AGED;
MORBIDITY;
PREVALENCE;
TRANSFERRIN;
UNITED STATES;
|
EID: 0037067886
PISSN: 00039926
EISSN: None
Source Type: Journal
DOI: 10.1001/archinte.162.15.1769 Document Type: Article |
Times cited : (13)
|
References (26)
|